Picture of ConvaTec logo

CTEC ConvaTec News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

REG-Convatec Group PLC Convatec Group PLC: Scrip Dividend – Calculation Price

============

Convatec Group PLC (CTEC)
Convatec Group PLC: Scrip Dividend – Calculation Price

25-Aug-2023 / 19:12 GMT/BST

═══════════════════════════════════════════════════════════════════════════════════

25 August 2023

                                Convatec Group Plc
                           ("Convatec" or "the Company")

                        Scrip Dividend – Calculation Price

On 2 August 2023, the Board of Directors of Convatec Group Plc (“Convatec” or  “the
Company”)  declared  an  interim  dividend  of  1.769  cents  per  share  (“Interim
Dividend”).  This  Interim  Dividend  is  to  be  paid  on  28  September  2023  to
shareholders on  the share  register as  of  18 August  2023 (“Record  Date”).  The
Interim Dividend is payable in cash, in sterling to holders of ordinary shares. The
chosen exchange rate for  this payment is US$1.282  /£1.00, determined on 1  August
2023, giving a  total sterling dividend  of £28,226,583. A  scrip dividend will  be
made available for this Interim Dividend, allowing shareholders to elect to receive
their dividend in the form of new ordinary shares.

The “Calculation  Price” for  the issue  of  new ordinary  shares under  the  scrip
dividend scheme is:

                     221.0 pence for each new ordinary share.

This is equivalent to 1 new share for approximately 160.14 shares held prior to the
                        ex-dividend date of 17 August 2023.

The Calculation Price is the average of the middle market quotations of a  Convatec
share, derived from  the London Stock  Exchange Daily Official  List, for the  five
consecutive business days from 17 August to 23 August 2023 (inclusive).

The latest  date for  receipt of  elections to  participate in  the scrip  dividend
scheme for the Interim Dividend is 7 September 2023. Shareholders must return their
mandate form by 5pm (BST) or otherwise  input their CREST elections to be  received
by the  Company’s registrar,  Computershare,  by 3pm  (BST)  on 7  September  2023.
Elections received after  this deadline  will apply to  subsequent dividends  only.
Unless revoked  by you,  your scrip  dividend election  will apply  for all  future
dividends for which  a scrip  dividend is  offered. Evergreen  elections for  CREST
shareholders cannot be accepted and elections will revert to cash by default  after
the payment of each dividend.

Details of the scrip dividend scheme are available at
 1 https://www.convatecgroup.com/investors/shareholder-centre/dividend-information/

TIMETABLE

Key dates in respect of the scrip dividend scheme for the Interim Dividend are:

Ex-dividend Date                                      17 August 2023
Record Date                                           18 August 2023
Scrip calculation price determined                    17-23 August 2023 (inclusive)
Mandate  delivery   deadline  for   Shares  held   in 3.00 p.m. on 7 September 2023
uncertificated form
Mandate  delivery   deadline  for   Shares  held   in 5.00 p.m. on 7 September 2023
certificated form
Announcement of the total amount of new shares to  be 15 September 2023
issued
Dividend payment date                                 28 September 2023
Dispatch of statement in accordance with section 7 of 28 September 2023
Scheme

 

Enquiries

 

Kate Postans, VP Investor Relations                                            +44
(0)782 644 7807

 

ir@convatec.com 

 

Convatec Group Plc’s LEI code is 213800LS272L4FIDOH92

 

About Convatec

 

Pioneering trusted medical solutions to improve  the lives we touch: Convatec is  a
global medical  products and  technologies company,  focused on  solutions for  the
management of chronic conditions,  with leading positions  in advanced wound  care,
ostomy care, continence care and infusion  care. With around 10,000 colleagues,  we
provide our products and services in almost  100 countries, united by a promise  to
be forever  caring. Our  solutions  provide a  range  of benefits,  from  infection
prevention and protection of at-risk skin, to improved patient outcomes and reduced
care costs.  Group  revenues  in 2022  were  over  $2 billion.  The  company  is  a
constituent of the FTSE 100 Index (LSE: CTEC). To learn more about Convatec, please
visit  2 www.convatecgroup.com.

 

 

═══════════════════════════════════════════════════════════════════════════════════

Dissemination of a Regulatory Announcement, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.

═══════════════════════════════════════════════════════════════════════════════════

   ISIN:          GB00BD3VFW73
   Category Code: DIV
   TIDM:          CTEC
   LEI Code:      213800LS272L4FIDOH92
   Sequence No.:  267296
   EQS News ID:   1712219


    
   End of Announcement EQS News Service

   ══════════════════════════════════════════════════════════════════════════

    3 fncls.ssp?fn=show_t_gif&application_id=1712219&application_name=news&site_id=refinitiv

References

   Visible links
   1. https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=redirect&url=9453ea3ef4b2b9c62bd8629b036f16c6&application_id=1712219&site_id=refinitiv&application_name=news
   2. https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=redirect&url=26f8de477e9a42123589f91471356e0b&application_id=1712219&site_id=refinitiv&application_name=news


============

Recent news on ConvaTec

See all news